Eicosanoids are the oxidative metabolites of the Essential fatty Acids (EFA) containing 20 carbon atoms (in Greek Eicosa means twenty). Prostaglandins, prostacyclins, thromboxanes and leukotrienes are the main Eicosanoids. Each of these Eicosanoids has an important role in the human health. The Eicosanoids formation may proceed through one of several alternative enzymatic routes. The precursor highly unsaturated fatty acids (HUFA) are esterified with cholesterol. Desaturation and elongation of the essential fatty acids, linoleic (18:2,n-6) and alpha-linolenic (18:3,n-3) lead to the formation of dihomo-gamma-linolenic acid, DHLA (20:3,n-6), arachidonic acid, AA (20:4, N-6) and timnodonic acid (20:5,n-3;5,8,11,14,17-eicosa pentaenoic acid) more commonly known as EPA. The major cyclooxygenase product in platelets is TXA2, a potent and important inducer of platelet aggregation and vaso-constriction. TXA2, formed during platelet activation, is highly unstable, with half life of 30 seconds, being rapidly hydrolyzed to inactive TXB2.
Acute deficiency of essential fatty acids (EFA) in children results in growth failure and increased susceptible to infection. A chronic deficiency (a low ratio of EFA to non-essential fatty acids in the body) causes faulty structure of cell membranes and increased prevalence of chronic degenerative diseases such as atherosclerosis.